6505--Acamprosate CA EC Tablets
Closed Solicitation Posted
- Solicitation number
- 36E79726R0021
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Nicholas McGregor nicholas.mcgregor@va.gov (708) 786-4934
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center seeks a single award for Acamprosate Calcium 333mg Enteric Coated Tablets in 180-count unit-of-use bottles, with proposals due May 28, 2026 at 2:30 PM CDT. No set-aside applies; this is an unrestricted acquisition.
Estimated annual usage is 33,661 bottles across all participating agencies: the Department of Veterans Affairs, Department of Defense, Indian Health Service, Bureau of Prisons, Captain James A. Lovell Federal Health Care Center, and Option 2 State Veteran Homes. Distribution occurs through Pharmaceutical Prime Vendor networks. The contract includes a base year and four one-year option periods.
Products must be FDA-approved with acceptable current Good Manufacturing Practice status at all identified manufacturing facilities, verified FDA clearance under the specific NDA/ANDA/BLA, and compliance with Drug Supply Chain Security Act requirements including serialized tracking and NABP Trading Directory registration. Each offeror must submit a unique 11-digit National Drug Code number specific to their company. Distributors must provide a Letter of Commitment from the manufacturer and maintain the same manufacturer for contract duration unless the Contracting Officer approves changes.
Pricing must include an embedded 0.5% Cost Recovery Fee, with unit prices not exceeding two decimal places, for the base year and all four option periods. The implementation period is up to 60 calendar days following award, during which contractors must establish business-to-business agreements with Pharmaceutical Prime Vendors and ensure product availability at their distribution centers. Award is made to the lowest-priced, technically acceptable offer, with past performance evaluated to determine contractor responsibility. Non-small businesses must submit an approved subcontracting plan if contract value exceeds $900,000. The NAICS code is 325412, Pharmaceutical Preparation Manufacturing. Proposals are submitted via email to Deborah.Fassl@va.gov and Nicholas.McGregor@va.gov.
Notice text
N/A
Files
| File | Type | Posted |
|---|---|---|
| 36E79726R0021.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| 6505--Acamprosate CA EC Tablets | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity